Related Experiment Video

Updated: Apr 5, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.9K

Molecular imaging-its current role in cancer

S McDermott1, A Kilcoyne2

  • 1From the Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, USA mcdermott.shaunagh@mgh.harvard.edu.

QJM : Monthly Journal of the Association of Physicians
|August 9, 2015
PubMed

Insights

Molecular imaging agents are revolutionizing oncology by enabling earlier cancer diagnosis and personalized treatment. This innovative approach visualizes specific molecules, improving patient outcomes and drug development.

Area of Science:

  • Oncology
  • Medical Imaging
  • Molecular Biology

Background:

  • Medical imaging is crucial in modern oncology.
  • Conventional imaging focuses on anatomy.
  • Molecularly targeted imaging agents represent the future.

Purpose of the Study:

  • To highlight the transformative potential of molecular imaging in oncology.
  • To explain the principles of molecular imaging.
  • To discuss its impact on personalized medicine and drug development.

Main Methods:

  • Utilizing imaging probes to visualize specific molecules of interest.
  • Differentiating molecular imaging from conventional anatomical imaging.

Main Results:

  • Molecular imaging allows for earlier cancer diagnosis.
  • It enables assessment of early treatment response.
  • It aids in predicting treatment effectiveness.

Conclusions:

  • Molecular imaging is poised to significantly impact oncology and personalized medicine.
  • It offers advancements in earlier diagnosis and treatment monitoring.
  • It promises to streamline drug development processes.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.9K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
756
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.1K